MedTrace Logo

Study to Assess the Safety and Effectiveness of Beltavac® Polymerized With Cat Dander

NCT04207697 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34

Last updated 2023-05-11

No results posted yet for this study

Summary

Non-interventional Study to Assess the Safety and Effectiveness Profile of a SCIT Therapy With Beltavac® Polymerized With Cat Dander in allergic patients

Conditions

  • Rhinoconjunctivitis With or Without Allergic Asthma

Interventions

BIOLOGICAL

Beltavac® Polymerized with cat dander

Adminstration of Beltavac® Polymerized with cat dander according to the routine clinical practice

Sponsors & Collaborators

  • Probelte Pharma S.L.U.

    lead INDUSTRY

Principal Investigators

  • Carolina Mérida · San Cecilio Universitary Hospital

Eligibility

Min Age
12 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-01
Primary Completion
2023-02-09
Completion
2023-02-09

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04207697 on ClinicalTrials.gov